• 2EyesVision
  • $
  • SimVis Gekko featured in APAO2025 hot-topic session on presbyopia solutions

SimVis Gekko featured in APAO2025 hot-topic session on presbyopia solutions

Share it:

Apr 5, 2025

From live demos to global collaboration, SimVis Gekko took center stage at APAO2025 in New Delhi—shaping the future of patient-centered IOL selection.

New Delhi, India – The APAO2025 Congress in New Delhi marked a milestone for 2EyesVision, with SimVis Gekko featured in a high-profile hot-topic session and key symposiums addressing the future of presbyopia treatment.

In the session titled “Looking for a Solution to Presbyopia: What Options Do We Have Today?”, Helena Prior Filipe and Krueger Ronald led live simulations using SimVis Gekko. Attendees witnessed in real time how the device is reshaping preoperative IOL selection, offering a precise, interactive, and patient-specific approach to visual planning.

Beyond the live demonstrations, 2EyesVision also participated in a compelling symposium alongside Prof. Moore (Belfast) and Dr. Ashraf Armia (Glasgow, UK), focusing on optimal IOL selection, the role of patient education, and the importance of clinician–patient partnership.

As part of this session, Candela Rodríguez presented the talk:

“Artis Symbiose and SimVis Gekko – Redefining Vision Experience,”
highlighting how SimVis enables patients to preview the vision offered by premium IOLs, such as the Artis Symbiose by Cristalens International, before surgery.

These discussions underscored SimVis Gekko’s value not only as an optical innovation, but as a powerful educational and communication tool in refractive and cataract surgery.

If you’re attending APAO2025, don’t miss your chance to experience SimVis Gekko firsthand at booth SP246. It’s not just innovation—it’s a new way to envision the future of presbyopia solutions.

 

Are you exploring smarter ways to guide IOL decisions for presbyopia patients?

SimVis Gekko is helping practices worldwide personalize care and enhance surgical planning. Contact our team to discover how it can support your clinical goals.

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *